Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy
EE-DES-TIEF
1 other identifier
interventional
100
2 countries
3
Brief Summary
This study investigates the potential for temporally-interfering electric field stimulation (TIEFS) to treat epilepsy. In this case series within and between subjects design, the impact of TIEFS on epilepsy biomarkers was studied in patients with medial temporal lobe epilepsy. Secondary analyses examine the underlying physiological effects of TIEF on local brain activity and brain networks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 16, 2019
CompletedFirst Submitted
Initial submission to the registry
October 25, 2024
CompletedFirst Posted
Study publicly available on registry
December 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2030
July 20, 2025
July 1, 2025
11.5 years
October 25, 2024
July 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction of Interictal Biomarkers of Epilepsy
Three epilepsy interictal biomarkers will be examined: Interictal epileptiform discharges (IEDs), pathologic ripples (PRs), and high-frequency oscillations (HFOs). Each is recorded from intracranial field potential recordings (also 'intracranial electroencephalography' or iEEG). IEDs can also be recorded from scalp EEG where this is available (it is typically not recorded during iEEG studies). These features of the intracranial EEG will be measured at baseline, during sham TIEFS, and during active TIEFS. The primary outcome is the change in the number of IEDs during the baseline, sham, or active TIEFS periods. The secondary outcome is the number of PRs and HFOs during these periods. Semi-automated detection of IEDs, PRs, and HFOs will be performed using the freely available and validated AnyWave software ( INSERM and Aix-Marseille University) and its 'Delphos' detector. IEDs, PRs, and HFOs rates per minute will be determined.
From enrollment until the end of the admission for each patient (the admission is typically 7-14 days in duration).
Study Arms (1)
Temporally-Interfering Electrical Field Central Nervous System Stimulation
EXPERIMENTALParticipants in this arm receive temporally-interfering electric fields stimulation.
Interventions
Temporally-interfering electric field stimulation is a candidate non-invasive means to stimulate and modulate the nervous system. We do not know of any other trials of this method in epilepsy patients.
Eligibility Criteria
You may qualify if:
- Patients undergoing invasive intracranial EEG studies
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Davislead
- Emory Universitycollaborator
- St. Anne's University Hospital Brno, Czech Republiccollaborator
- Semmelweis Universitycollaborator
- Hôpital de la Timone (MARSEILLE)collaborator
Study Sites (3)
UC Davis Medical Center
Sacramento, California, 95817, United States
Emory University Hospital
Atlanta, Georgia, 30322, United States
St. Anne Hospital, Masaryk University
Brno, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2024
First Posted
December 4, 2024
Study Start
January 16, 2019
Primary Completion (Estimated)
July 1, 2030
Study Completion (Estimated)
July 1, 2030
Last Updated
July 20, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- At the completion of the studies.
- Access Criteria
- Data will be shared upon request to the investigative team for non-commercial and academic use.
Deidentified IPD will be shared with other researchers at the completion of the study. IPD in this study consists of the anatomical location of electrode contacts, electrophysiological recordings, field models of the carrier fields and interference envelope. IPD also includes neuroimaging, and key data from the clinical neurophysiology reports. All data will be fully de-identified.